APVO News and Press, Aptevo Therapeutics Inc. From 12/02/20

Aptevo went up hugely on positive phase 1 data in AML. The company develops bispecific antibodies against cancer. Although early stage, this is a definite candidate for my watchlist. For further details see: Aptevo: Positive Early Stage Data Makes This Highly Interesting...

Aptevo Therapeutics ([[APVO]] +10.0%) announces that it has expanded its ADAPTIR bispecific platform technology to include a new multi-specific platform technology, ADAPTIR-FLEX™. Aptevo also announced that it has developed a new bispecific candidate, APVO442, that utilizes ADAPTI...

New Bispecific Therapeutic Candidate APVO442 uses ADAPTIR-FLEX Platform Technology APVO442 is a Unique T-Cell Engager Designed to Target PSMA and CD3 for the Treatment of Prostate Cancer SEATTLE, WA / ACCESSWIRE / December 2, 2020 / Aptevo Therapeutics Inc. ("Aptevo" or the "Compan...

SEATTLE, WA / ACCESSWIRE / November 19, 2020 / Aptevo Therapeutics Inc. ("Aptevo") (NASDAQ:APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ bispecific technology platform, today announced that it has received an ...

Gainers: Naked Brand (NAKD) +116%.Phoenix New Media (FENG) +48%.Titan Pharmaceuticals (TTNP) +36%.HighPoint Resources (HPR) +32%.Arcimoto (FUV) +32%.Ayro (AYRO) +29%.CIIG Merger (CIIC) +27%.Aptevo Therapeutics (APVO) +27%.Sonos (SONO) +27%.Blink Charging (BLNK) +23%.Losers: Ebang In...

Gainers: Medigus (MDGS) +30%, Aptevo Therapeutics (APVO) +29%, Corcept Therapeutics (CORT) +23%, Opiant Pharmaceuticals (OPNT) +15%, Aquestive Therapeutics (AQST) +11%.Losers: MeiraGTx Holdings (MGTX) -11%, Kintara Therapeutics (KTRA) -10%,&#x...

Phoenix New Media (FENG) +62% after announcing special distribution.Hudson Capital (HUSN) +37%.Aptevo Therapeutics (APVO) +31% following a disclosure that 42.5% shareholder Tang Capital Partners offered to buy the remaining shares for $50/share in cash.Corcept Therapeutics...

Aptevo Therapeutics (APVO) +35.7% after-hours following a disclosure that 42.5% shareholder Tang Capital Partners offered to buy the remaining shares for $50/share in cash.Shares have surged nearly 6x this month since announcing a complete remission in a Phase 1 clinical trial evaluating...

Gainers: Phoenix Tree (DNK) +91%.Naked Brand (NAKD) +64%.Kazia Therapeutics (KZIA) +32%.Micro Focus International (MFGP) +32%.BELLUS Health (BLU) +31%.InnSuites Hospitality Trust (IHT) +27%.FuelCell Energy (FCEL) +27%.Ashford Hospitality Trust (AHT) +24%.CIIG Merger (CIIC) ...

SEATTLE, WA / ACCESSWIRE / November 16, 2020 / Aptevo Therapeutics Inc. ("Aptevo") (NASDAQ:APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ bispecific technology platform, and Alligator Bioscience ("Alligator") (...